LUMOSA Board of Directors approved the convening
of the 2022 Annual shareholders' Meeting
Date of events
2022/03/04
To which item it meets
paragraph 17
Statement
1.Date of the board of directors resolution:2022/03/04
2.General shareholders' meeting date:2022/05/24
3.General shareholders' meeting location:Rm. 423, 4F.,Building E, No. 19-11,
Sanchong Rd., Nangang Dist., Taipei City 115, Taiwan (R.O.C.)
4.Cause for convening the meeting I.Reported matters:
(1) 2021 Business Reports。
(2) 2021Audit Committee's review report.
(3) Execution status of the sound business plan for share issuance.
(4) Execution status of the resolution for issuance of common shares for
cash in private placement.
5.Cause for convening the meeting II.Acknowledged matters:
(1) Adoption of the 2021 Business Report and Financial Statement。
(2) Adoption of the Proposal for 2021 Deficit Compensation。
6.Cause for convening the meeting III.Matters for Discussion:
(1)Discussion of amendment of the Company's Articles of Incorporation
(2)Discussion of amendment of the Regulation Governing the Acquisition
and Disposal Assets.
(3)To issue common shares via private placement.
(4)To release the prohibition on directors or its representatives from
participation in competitive business
7.Cause for convening the meeting IV.Election matters:None
8.Cause for convening the meeting V.Other Proposals:None
9.Cause for convening the meeting VI.Extemporary Motions:None
10.Book closure starting date:2022/03/26
11.Book closure ending date:2022/05/24
12.Whether to announce proposal for profit distribution
or loss off-setting in "Status of dividend distribution
" section of MOPS:YES
13.Please explain the reason for not announcing proposal
for profit distribution or loss off-setting:N/A
14.Any other matters that need to be specified:
Shareholders with over 1% holdings could propose a proposal to LUMOSA
from 2022/03/21 to 2022/03/31 16：30 PM. The address of proposition
receiving office: Business Administration Division,4F., No.3-2,
Park St., Nangang Dist., Taipei City 11503, Taiwan
(Nangang Software Park II Tower H)
Attachments
Original Link
Original Document
Permalink
Disclaimer
Lumosa Therapeutics Co. Ltd. published this content on 04 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 March 2022 08:55:02 UTC.
LUMOSA THERAPEUTICS CO., LTD. is a Taiwan-based company principally engaged in the development of new drugs. The Company is engaged in the development of new drugs for unmet medical needs in the fields of central nervous system (CNS), oncology, and inflammatory diseases. The Company is engaged in scientific licensing and new drug development under the reSEARCH and DEVELOPMENT model.
LUMOSA THERAPEUTICS CO., LTD. 
